Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Esperion Theraptc (ESPR)

Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 348,498
  • Shares Outstanding, K 189,401
  • Annual Sales, $ 116,330 K
  • Annual Income, $ -209,250 K
  • 60-Month Beta 0.84
  • Price/Sales 3.11
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ESPR with:

Options Overview Details

View History
  • Implied Volatility 136.94% ( +14.34%)
  • Historical Volatility 93.90%
  • IV Percentile 59%
  • IV Rank 21.14%
  • IV High 450.04% on 05/09/23
  • IV Low 53.00% on 08/16/23
  • Put/Call Vol Ratio 1.04
  • Today's Volume 3,221
  • Volume Avg (30-Day) 5,410
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 119,251
  • Open Int (30-Day) 99,117

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.17
  • Number of Estimates 5
  • High Estimate 0.28
  • Low Estimate -0.38
  • Prior Year -0.79
  • Growth Rate Est. (year over year) +78.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8100 +3.31%
on 04/18/24
3.4000 -45.00%
on 04/08/24
-0.1800 (-8.78%)
since 03/18/24
3-Month
1.6500 +13.33%
on 01/19/24
3.4000 -45.00%
on 04/08/24
-0.2800 (-13.02%)
since 01/18/24
52-Week
0.7000 +167.14%
on 10/12/23
3.4000 -45.00%
on 04/08/24
+0.5500 (+41.67%)
since 04/18/23

Most Recent Stories

More News
Esperion Therapeutics: Q4 Earnings Snapshot

Esperion Therapeutics: Q4 Earnings Snapshot

ESPR : 1.8700 (+1.63%)
Esperion Therapeutics: Q3 Earnings Snapshot

Esperion Therapeutics: Q3 Earnings Snapshot

ESPR : 1.8700 (+1.63%)
Esperion Therapeutics: Q2 Earnings Snapshot

Esperion Therapeutics: Q2 Earnings Snapshot

ESPR : 1.8700 (+1.63%)
Esperion (ESPR) Q1 Earnings Miss Estimates, Sales Beat, Stock Up

Esperion (ESPR) reports mixed first-quarter 2023 results, wherein earnings miss and revenues beat estimates. The stock of the company surges 5% on Tuesday. The company maintains 2023 guidance.

ADMA : 6.20 (+2.65%)
ESPR : 1.8700 (+1.63%)
ANIX : 3.10 (+1.64%)
ALLO : 3.46 (-1.42%)
Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates

Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of -21.54% and 15.71%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ESPR : 1.8700 (+1.63%)
XBIO : 4.14 (+7.25%)
Esperion Therapeutics: Q1 Earnings Snapshot

Esperion Therapeutics: Q1 Earnings Snapshot

ESPR : 1.8700 (+1.63%)
Stevanato Group (STVN) Q1 Earnings Lag Estimates

Stevanato (STVN) delivered earnings and revenue surprises of -7.69% and 1.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

STVN : 28.40 (-1.59%)
ESPR : 1.8700 (+1.63%)
Esperion Therapeutics (ESPR) Down 74.3% Since Last Earnings Report: Can It Rebound?

Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ESPR : 1.8700 (+1.63%)
Esperion (ESPR) Plummets 54% Over Milestone Payment Row

An SEC filing by Esperion (ESPR) reveals that partner Daiichi Sankyo disagrees with the company's assessment that cardiovascular outcome CLEAR study data would support milestone payments.

ADPT : 2.34 (-4.30%)
ESPR : 1.8700 (+1.63%)
ATRA : 0.6917 (-3.25%)
RCEL : 8.87 (-5.44%)
Stock Index Futures Mixed as Bank Jitters Weigh on Sentiment, ECB Decision in Focus

March S&P 500 futures (ESH23) are down -0.10%, and March Nasdaq 100 E-Mini futures (NQH23) are up +0.21% this morning after three major U.S. benchmark indices ended the regular session mixed as signs of...

ESH23 : 3,957.05s (-0.09%)
NQM24 : 17,370.50 (-1.01%)
CS : 0.8858 (+0.99%)
META : 501.80 (+1.54%)
AMZN : 179.22 (-1.14%)
MSFT : 404.27 (-1.84%)
ADBE : 473.18 (-0.27%)
PATH : 19.04 (-0.42%)
LPSN : 0.5577 (-4.22%)
ESPR : 1.8700 (+1.63%)
CVI : 32.55 (-2.57%)
ENVX : 6.01 (-9.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Esperion Therapeutics, Inc. is a pharmaceutical company focused on the development of oral lipid-management treatments for cardiovascular diseases caused by elevated levels of LDL-C (bad cholesterol).

See More

Key Turning Points

3rd Resistance Point 2.2167
2nd Resistance Point 2.1233
1st Resistance Point 1.9967
Last Price 1.8700
1st Support Level 1.7767
2nd Support Level 1.6833
3rd Support Level 1.5567

See More

52-Week High 3.4000
Fibonacci 61.8% 2.3686
Fibonacci 50% 2.0500
Last Price 1.8700
Fibonacci 38.2% 1.7314
52-Week Low 0.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar